Comment on

• Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation.

  Kishima H, Mine T, Fukuhara E, Kitagaki R, Asakura M, Ishihara M. Kishima H, et al. JACC Clin Electrophysiol. 2022 Nov;8(11):1393-1404. doi: 10.1016/j.jacep.2022.08.004. Epub 2022 Oct 26. JACC Clin Electrophysiol. 2022. PMID: 36424008 Clinical Trial.
• Should SGLT2 Inhibitors Be Part of the Standard Treatment for Atrial Fibrillation in Type 2 Diabetes?

  San Antonio R. San Antonio R. JACC Clin Electrophysiol. 2023 Feb;9(2):263-264. doi: 10.1016/j.jacep.2022.11.036. JACC Clin Electrophysiol. 2023. PMID: 36858699 No abstract available.